Tech Company Financing Transactions
Caldan Therapeutics Funding Round
On 11/5/2015, Caldan Therapeutics raised $6.9 million in Series A investment from Epidarex Capital and Scottish Widows Investment Partnership.
Transaction Overview
Company Name
Announced On
11/5/2015
Transaction Type
Venture Equity
Amount
$6,850,000
Round
Series A
Investors
Epidarex Capital (Lead Investor) (Elizabeth Roper)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
No.11 The Square University Ave.
Glasgow, G12 8QQ
UK
Glasgow, G12 8QQ
UK
Phone
Undisclosed
Email Address
Not Recorded
Overview
Caldan, a spin-out company from the Universities of Glasgow and Southern Denmark, is developing novel therapeutics targeting free fatty acid receptors for Type 2 Diabetes (T2D) and other potential indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 11/5/2015: PeerSpace venture capital transaction
Next: 11/5/2015: BuildingConnected venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs